Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New agents for treating neurological disorders disclosed in recent patent literature

Sep. 10, 2007

Studies advance clinical development of almorexant for insomnia

Sep. 10, 2007

Tikvah and Chakra to codevelop four novel antipsychotic compounds

Sep. 10, 2007

Update on ReNeuron's ReN-001 stem cell therapy for stroke

Sep. 10, 2007

Extinction of learned responses to fear regulated by Cdk5 signaling in hippocampus / News in Context

Sep. 10, 2007

Positive results for extension of Akela Pharma's phase IIb Fentanyl Taifun trial

Sep. 7, 2007

BioDelivery and Meda enter North American BEMA Fentanyl license agreement

Sep. 7, 2007

Positive results for Next Pharmaceuticals' study of Relora

Sep. 7, 2007

Lundbeck and Takeda to codevelop and comarket new therapies for psychiatric disorders

Sep. 7, 2007

Positive results for Clinical Data's pivotal phase III study of vilazodone for depression

Sep. 6, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...